Studies have shown that the overexpression and/or activation of Akt occurs in gastric cancer (20,21), and that the phosphoinositide 3-kinase/Akt signaling pathway is important in the chemoresistance of gastric cancer cells against the cell death induced by etoposide and doxorubicin (22). Here, AKT1 is linked to gastric cancer.